S1118 Safety and Efficacy of the Novel EndoRotor Device for the Treatment of Walled-Off Pancreatic Necrosis (WOPN): A Systematic Review and Meta-Analysis

Abstract

Table 1. Results of comparison of technical success, clinical success, and rate of adverse events between the transgastric and transduodenal/transjejunal approach METHOD 1-Including studies with patients in both arms N of studies Pooled odds ratio (TG vs. TD/TJ) 95% CI p-value Adverse events 6 1.58 0.46-5.45 0.47 Clinical success 3 0.30 0.06-1.48 0.14 Technical success 3 0.30 0.05-1.89 0.20 METHOD 2-: Including all the studies N of Studies (TG vs TD/TJ) AE(%) 95% CI p-value Adverse events 9 vs 15 27.5% vs 15.2% 17.1%-41.1%) vs (9.5%-23.6%) 0.07 Clinical success 6 vs 13 83.3% vs 91.7% (71.0%-91.0%) vs (82.4%-96.3%) 0.16 Technical success 9 vs 15 91.3% vs 95.6% 83.6%-95.6%) vs 90.7%-97.7%) 0.22 S1118 Safety and Efficacy of the Novel EndoRotor Device for the Treatment of Walled-Off Pancreatic Necrosis (WOPN): A Systematic Review and Meta-Analysis